Literature DB >> 7744813

The pleckstrin homology domain in insulin receptor substrate-1 sensitizes insulin signaling.

M G Myers1, T C Grammer, J Brooks, E M Glasheen, L M Wang, X J Sun, J Blenis, J H Pierce, M F White.   

Abstract

The NH2 terminus of insulin receptor substrate-1 (IRS-1) contains a pleckstrin homology (PH) domain. We deleted the PH domain in IRS-1 (IRS-1 delta PH) and expressed the mutant in Chinese hamster ovary and 32D cells. During insulin stimulation, IRS-1 delta PH is poorly tyrosine-phosphorylated in CHO cells, but undergoes serine/threonine phosphorylation. Similarly, IRS-1 delta PH fails to undergo insulin-stimulated tyrosine phosphorylation in 32D cells, which uncouples the activation of phosphatidylinositol 3'-kinase and p70s6k from the endogenous insulin receptors. Overexpression of the insulin receptor in 32DIR cells, however, restores tyrosine phosphorylation of IRS-1 delta PH and rescues insulin responses including mitogenesis. Thus, while the PH domain is not required for the engagement of downstream signals, it is one of the elements in the NH2 terminus of IRS-1 that is needed for a sensitive coupling to insulin receptors, especially at ordinary receptor levels found in most cells and tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744813     DOI: 10.1074/jbc.270.20.11715

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

2.  Cellular compartmentalization in insulin action: altered signaling by a lipid-modified IRS-1.

Authors:  K M Kriauciunas; M G Myers; C R Kahn
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  The role of the PH domain in the signal-dependent membrane targeting of Sos.

Authors:  R H Chen; S Corbalan-Garcia; D Bar-Sagi
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 4.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

5.  A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.

Authors:  S Tanaka; J R Wands
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  The N-terminal pleckstrin, coiled-coil, and IQ domains of the exchange factor Ras-GRF act cooperatively to facilitate activation by calcium.

Authors:  R Buchsbaum; J B Telliez; S Goonesekera; L A Feig
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

7.  Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors.

Authors:  M Andjelković; T Jakubowicz; P Cron; X F Ming; J W Han; B A Hemmings
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

8.  A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling.

Authors:  G A Rodrigues; M Falasca; Z Zhang; S H Ong; J Schlessinger
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

9.  The pleckstrin homology (PH) domain-interacting protein couples the insulin receptor substrate 1 PH domain to insulin signaling pathways leading to mitogenesis and GLUT4 translocation.

Authors:  Janet Farhang-Fallah; Varinder K Randhawa; Anjaruwee Nimnual; Amira Klip; Dafna Bar-Sagi; Maria Rozakis-Adcock
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration.

Authors:  T Noguchi; T Matozaki; K Inagaki; M Tsuda; K Fukunaga; Y Kitamura; T Kitamura; K Shii; Y Yamanashi; M Kasuga
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.